anti-Mouse (Murine) Chromogranin A antibody for Immunohistochemistry (Formalin-fixed Sections)

Recommended Chromogranin A Antibody

Antigen
Chromogranin A (CHGA) Antibodies
  • fj05f09
  • si:dkey-177p2.2
  • wu:fj05f09
  • zgc:101749
  • zgc:56075
  • CHGA
  • ChrA
  • CGA
  • cgA
  • chromogranin A
  • uncharacterized CHGA
  • chga
  • CHGA
  • Chga
Reactivity
Human, Monkey, Mouse (Murine), Pig (Porcine), Rat (Rattus)
707
213
176
161
134
10
7
5
4
3
2
2
1
1
Host
Mouse
437
271
21
5
1
1
Clonality
Monoclonal
Conjugate
PE
31
20
16
16
15
14
14
14
14
14
14
14
14
14
14
14
14
14
14
7
7
7
7
7
7
6
1
1
1
1
1
Application
Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
417
394
256
237
211
168
106
25
16
14
13
13
8
6
3
Options

Available images

Catalog No. ABIN6160783
$ 441.85
Plus shipping costs $45.00
Relevance Score ABIN Application Conjugate Host Isotype Epitope Clonality References Details
7 ABIN6160775 FACS IF IHC (f) APC Mouse IgG1, kappa LK2H10 0
7 ABIN6160782 FACS IF IHC (f) PerCP Mouse IgG1, kappa LK2H10 0
7 ABIN6160786 FACS IF IHC (f) Mouse IgG1, kappa LK2H10 0
1 ABIN6160763 FACS IF IHC (f) CF®568 Mouse IgG1, kappa LK2H10 0
1 ABIN6160773 FACS IF IHC (f) CF®594 Mouse IgG1, kappa LK2H10 0
1 ABIN6160757 FACS IF IHC (f) CF®647 Mouse IgG1, kappa LK2H10 0
1 ABIN6160753 FACS IF IHC (f) CF®640R Mouse IgG1, kappa LK2H10 0
1 ABIN6160761 FACS IF IHC (f) CF®660R Mouse IgG1, kappa LK2H10 0
1 ABIN6160767 FACS IF IHC (f) CF®680 Mouse IgG1, kappa LK2H10 0
1 ABIN6160751 FACS IF IHC (f) CF405M Mouse IgG1, kappa LK2H10 0
1 ABIN6160749 FACS IF IHC (f) CF®405S Mouse IgG1, kappa LK2H10 0
1 ABIN6160771 FACS IF IHC (f) CF®488A Mouse IgG1, kappa LK2H10 0
1 ABIN6160755 FACS IF IHC (f) CF®543 Mouse IgG1, kappa LK2H10 0
1 ABIN6160759 FACS IF IHC (f) CF®555 Mouse IgG1, kappa LK2H10 0
1 ABIN6160769 FACS IF IHC (f) CF®680R Mouse IgG1, kappa LK2H10 0
1 ABIN6160765 FACS IF IHC (f) CF®770 Mouse IgG1, kappa LK2H10 0
1 ABIN6160731 FACS IF IHC (f) CF®680R Mouse IgG1 LK2H10 PHE5 0
1 ABIN6160727 FACS IF IHC (f) CF®770 Mouse IgG1 LK2H10 PHE5 0
1 ABIN6160713 FACS IF IHC (f) CF405M Mouse IgG1 LK2H10 PHE5 0
1 ABIN6160711 FACS IF IHC (f) CF®405S Mouse IgG1 LK2H10 PHE5 0

General

Antigen Chromogranin A (CHGA) Antibodies
Reactivity Human, Monkey, Mouse (Murine), Pig (Porcine), Rat (Rattus)
(707), (213), (176), (161), (134), (10), (7), (5), (4), (3), (2), (2), (1), (1)
Host Mouse
(437), (271), (21), (5), (1), (1)
Clonality (Clone)
Monoclonal   ( )
Conjugate PE
(31), (20), (16), (16), (15), (14), (14), (14), (14), (14), (14), (14), (14), (14), (14), (14), (14), (14), (14), (7), (7), (7), (7), (7), (7), (6), (1), (1), (1), (1), (1)
Application Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
(417), (394), (256), (237), (211), (168), (106), (25), (16), (14), (13), (13), (8), (6), (3)
Supplier

Product details

Target Details Application Details Handling Images
Purpose Mouse Monoclonal anti-Chromogranin A (LK2H10), R-PE Conjugate
Characteristics Chromogranin A is present in neuroendocrine cells throughout the body, including the neuroendocrine cells of the large and small intestine, adrenal medulla and pancreatic islets. It is an excellent marker for carcinoid tumors, pheochromocytomas, paragangliomas, and other neuroendocrine tumors. Co-expression of chromogranin A and neuron specific enolase (NSE) is common in neuroendocrine neoplasms. Reportedly, co-expression of certain keratins and chromogranin indicates neuroendocrine lineage. The presence of strong anti-chromogranin staining and absence of anti-keratin staining should raise the possibility of paraganglioma. The co-expression of chromogranin and NSE is typical of neuroendocrine neoplasms. Most pituitary adenomas and prolactinomas readily express chromogranin. Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
Immunogen Human pheochromocytoma
Clone LK2H10
Isotype IgG1, kappa

Target Details

Product details Application Details Handling Images back to top
Antigen
Alternative Name Chromogranin A (CHGA Antibody Abstract)
Background Beta-Granin, CGA, CHGA, Chromogranin A Parathyroid Secretory Protein 1, ER-37, Pancreastatin, Parastatin, Parathyroid Secretory Protein 1, Pituitary Secretory Protein I, SP-I, Vasostatin I or II
Molecular Weight 68-75 kDa
Gene ID 1113, 150793
UniProt P10645
Pathways Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling

Application Details

Product details Target Details Handling Images back to top
Application Notes Does not react with guinea pig, sheep , or rabbit, others not known
  • Immunohistology formalin-fixed 0.25-0.5 μg/mL
  • Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer,  pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes
  • Immunofluorescence 0.5-1 μg/mL
  • Flow Cytometry 0.5-1 μg/million cells/0.1 mL
  • Optimal dilution for a specific application should be determined by user
Comment

PC12 cells. Adrenal gland, bowel, thyroid, pancreas, or pheochromocytoma.

Restrictions For Research Use only

Handling

Product details Target Details Application Details Images back to top
Format Liquid
Concentration 100 μg/mL
Buffer PBS/0.1 % BSA/0.05 % azide
Preservative Sodium azide
Precaution of Use This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Images

Product details Target Details Application Details Handling back to top
Supplier Images
 image for anti-Chromogranin A (CHGA) antibody (PE) (ABIN6160783) anti-Chromogranin A (CHGA) antibody (PE)
 image for anti-Chromogranin A (CHGA) antibody (PE) (ABIN6160783) anti-Chromogranin A (CHGA) antibody (PE) (Image 2)